Introduction
Human immunodeficiency virus (HIV)-1 infections are dominated by group M viruses which are classified into nine different subtypes (AeD, FeH, J, K). Circulating recombinant forms (CRFs) result from recombination between HIV-1 genotypes (subtypes or CRFs) within a dually infected person [1] . The AsiaePacific, representing more than 60% of the world's population is second only to sub-Saharan Africa in HIV-infection prevalence (5 million) and incidence (14%) [2] .
In Asia, country-specific epidemics feature different HIV genotypes and epidemics are of increasing viral diversity. Common regional genotypes are subtypes B and C, CRF01_AE and their recombinants. Cambodia, Myanmar, Thailand and Vietnam have been historically dominated by CRF01_AE, in China's Special Administrative Region of Hong Kong subtype B and CRF01_AE cocirculate, mainland China infections include B/C recombinants and subtype B infections are common in Japan [3] . Previously, we reported on Asian patients who were predominantly infected with CRF01_AE and subtype B [4] . Among patients for whom both HIV-1 protease and reverse transcriptase genotypes were determined, 6.4% were infected with discordant protease and reverse transcriptase genotypes, consisting mainly of subtype B and CRF01_AE components.
HIV genotype diversity is associated with the heterogeneity in the human subpopulations driving regional Asian epidemics [5] . Sexual transmission accounts for most infections globally. However, in the AsiaePacific, epidemics are diverse with concentrated, generalized and lowprevalence epidemics predominating in different countries. In many countries, epidemics have been historically concentrated in high-risk groups such as people who inject drugs (including street children), men who have sex with men (MSM), sex workers, their clients, and sexual partners. The epidemiology of the Asian pandemic is changing with HIV-1 being increasingly spread to lower-risk populations with onward sexual transmission to female partners of highrisk groups helping to sustain generalized epidemics [5] .
Phylogenetic analysis is a method of reconstructing relationships between genotypic sequences and is one strategy for studying viral transmission dynamics in humans. Phylogenetic studies cannot determine the direction of HIV-1 evolution or, consequently, the direction of transmission [6] . Classification of like sequences into clusters can, however, identify transmission networks thereby helping to quantify the evolving roles of cocirculating genotypes [7] . Although transmission network evaluations are not routinely incorporated in incidence reporting.
Under the TREAT Asia Studies to Evaluate Resistance monitoring (TASER-M) protocol [8] , patient characteristics are collected and infecting HIV-1 isolates are genotypically sequenced. We used TASER-M baseline data to evaluate associations between patient risk group and infecting genotype. For additional context, we complemented findings with descriptions of transmission clusters among our patients.
Methods
Patients were enrolled in a multicenter, prospective cohort [8] . Covariates included age at study entry, sex, patientreported HIV exposure, hepatitis B (HBV) and hepatitis C (HCV) coinfections, and indices of illness severity [CD4 T Phylogenetic analysis was used to identify transmission clusters among patients. Sequences not passing quality control evaluations (Virco BVBA, Beerse, Belgium) or with missing bases or gaps were excluded. By genotype, remaining sequences were trimmed using Clustal W, implemented in MEGA version 5 [10] . HXB2 and two CRF01_AE reference strains (TH.90, TH93, http://www.hiv. lanl.gov) were used to align subtype B and CRF01_AE sequences, respectively. Each reference strain set (B, CRF01_AE) served as outgroup for the other.
Phylogenetic topologies were generated by HIV Sequence Database PhyML (v2.4.4) using the method of maximum likelihood and general time reversible (GTR) plus gamma nucleotide substitution model, verified on the data [11] . Subtype B sequences were analyzed as a group. Due to resource limitations imposed by computations for the larger number of CRF01_AE sequences, phylogenies were generated by country. For Thailand, sequences were further separated into Bangkok metropolitan (Thai Metro) or regional urban centers (Thai Urban: Chiang Mai, Chiang Rai). Clustering was determined using bootstrapping with an acceptable 100 replicates.
included. Excepting antiretroviral therapy experience, differences existed for all covariates shown in Table 1 . Hong Kong patients were older (p < 0.001) and proportions of males within countries varied (p < 0.001). Patients from Thailand more frequently reported exposure as heterosexual contact (p < 0.001). Testing differed between countries for HBV (p < 0.001) and HCV (p < 0.001). In the 95% of patients naïve to antiretroviral therapy, country differences were found in CD4 counts (p < 0.001), log 10 HIV-1 RNA copies/mL (p < 0.001) and CDC classification (p < 0.001).
Of all genotypes, approximately 98% of patients were infected with either CRF01_AE [n Z 882 (81.2%)] or subtype B [n Z 178 (16.4%)]. Due to the small numbers of patients from some countries, HIV exposure was restricted to heterosexual and homosexual contact in country-specific analyses. Adjusted estimates for Hong Kong patients, suggested that homosexual contact had higher odds of subtype B infection [odds ratio (OR) Z 3.1; p < 0.001] whereas women had lower odds (OR Z 0.164; p < 0.023). In Thailand patients, after adjustment for HIV exposure, women had lower odds of subtype B infection (OR Z 0.396; p < 0.008). In Malaysia, no associations were found, possibly due to small cell sizes. There were insufficient data from the Philippines to perform the analysis.
For logistic regression analyses including all countries, patients having any IDU exposure were collapsed into one category, Any IDU. Univariate and adjusted estimates for all countries are shown in Table 2 . After adjustment, females had lower odds of subtype B infection (OR Z 0.4, p < 0.003). The overall heterogeneity test p value must be significant before category effects can be interpreted as contributing and both HIV-exposure (p < 0.001) and country (p < 0.001) were associated with infecting genotype. Patients reporting homosexual exposure had higher odds of being infected with subtype B, compared with heterosexual exposure (OR Z 2.4, p < 0.001). Compared with patients from Thailand, patients from Hong Kong (OR Z 8.9, p < 0.001), Malaysia (OR Z 3.6, p < 0.001), and the Philippines (OR Z 10.4, p < 0.001) had higher odds of subtype B infection.
Following quality control and sequence preparation, there were 114 subtype B and 753 CRF01_AE sequences from Thailand, Hong Kong, and Malaysia remaining for phylogenetic reconstruction. Subtype B analysis was performed on all sequences of this subtype, resulting in 15 groups [bootstrap value (BV) > 70%] comprising of clusters of 15 and nine, two triplets and 11 pairs (Figure 1 ). The cluster of 15 sequences (BV Z 99%) included men attending two sites in Hong Kongdone patient reporting heterosexual exposure, the others self-identifying as MSM [age in years: median: 40.7, minimum: 20.8, maximum: 58.6; symptomatic (CDC C or B): n Z 11/15 (73.3%)]. The ninegroup cluster (BV Z 99%) were male patients from two sites in Bangkok comprising of six patients reporting heterosexual contact and three MSM exposures [age in years: median: 30.8, minimum: 26.5, maximum: 36.0; symptomatic: n Z 5/9 (55.6%)]. Malaysian clusters included a male heterosexual/MSM pair, one each from two sites in Kuala Lumpur (BV Z 100%). The only clustering female isolate was similar to that of a male patient reporting unknown exposure.
Due to the large number of sequences, CRF01_AE analyses were performed individually for Hong Kong, Malaysia, Thai Metro, and Thai Urban. Ten groups were detected among 70 patients from Hong Kong ( Figure 2) ; a cluster of 10 [heterosexual; male: n Z 8, female: n Z 2; age in years: median: 55.7, minimum: 34.2, maximum: 70.8; symptomatic: n Z 8/10 (80.0%), BV Z 98%)], a cluster of eight [MSM: n Z 6, heterosexual female: n Z 1, male IDU: n Z 1; age in years: median: 41.0, minimum: 26.0, maximum: 46.7; symptomatic: n Z 5/8 (62.5%), BV Z 100%], and eight pairs (BVs > 70%). There was a relatively small amount of clustering found in collections of Thai Metro (n Z 288; pairs: n Z 4, BVs 99%) or Thai Urban sequences (n Z 344; pairs: n Z 9, triplets: n Z 1; BVs 70%). For the 51 isolates from Malaysia (Figure 3 ), five clusters were found; two clusters of four (BV > 91%), one including patients from two sites in Kuala Lumpur, and one pair (BV Z 79%). A subset of 14 CRF01_AE sequences clustered closer to outgroup subtype B and were verified using HIV Sequence Database BLAST (http://www.hiv.lanl.gov). Of these, one pair and one triplet included three IDU males (BV > 86%).
Overall for subtype B or CRF01_AE, patients in groups of eight or more (n Z 42) were treatment-naïve, aged 21e71 years [median: 39. 8 
Discussion
This large-scale study of HIV-1 genotypes in patients from South-East Asia showed country-specific differences in HIV epidemiology and increased subtype B infection among MSM patients, relative to patients reporting heterosexual exposures. Overall, one half of treatment-naïve patients were asymptomatic. By contrast, treatment-naïve patients in clusters of eight or more, were predominantly symptomatic with enhanced capacity for onward transmission.
Our study limitations include that TASER-M was not specifically designed to provide regional surveillance estimates. Intermediary transmission events outside our cohort are also unknown. Consequently, patients and networks X12022  R12017  R12101  R12135  X12033  R12129  R12070  R12021  R12119  X12024  R12138  R12106  R12133  X12007  X12043  R12005  X12038  R12041  R12032  R12111  X12052  R12120  R12144  R12033  R12028  X12047  R12112  R12081  X12032  R12016  R12001 R12067 R12145 X12017 Ref1.01 AE R12023 R12122 R12118 Ref2.01 AE  X12023  R12087  R12010  R12042  R12137  R12006  R12004  X12030  X12005  R12060  R12059  R12088  X12042  R12061  X12009  R12147  R12066  R12022  R12018  X12055  X12054  X12027  X12012  R12094  R12097  R12108  R12086  X12029  X12001  R12091  R12052  R12007 cannot be considered entirely representative of countries or the region. Computing restrictions possibly impacted the precision of our phylogenetic estimates, however, the methods are sufficiently robust to support interpretations. Additional investigation of Malaysian sequences, including those for people who inject drugs, is required. Malaysia is an environment where extensive recombination is reported and sequence variation may have reflected this [12] . Sequence preparation may have artifactually impacted on interpretations. Nevertheless, with the large number of contributing sequences, misclassification effects would be small.
In Asia, drivers of country-level HIV-1 epidemics are diverse [5] and our results show that different viral genotypes can predominate in specific patient risk-groups. Local prevention strategies need to target subpopulations at-risk for regional reductions. HIV-1 genotype is routinely available from drug resistance testing. Therefore, infecting HIV-1 genetic information from phylogenetic studies, partnered with assessment of de-identified patient characteristics, could enhance local epidemic surveillance and monitoring to better focus prevention efforts. Timely reporting of changes in HIV-1 genotype distributions, including entry of novel variants into local settings, could inform public health strategies and help arrest proliferation of HIV-1 clusters into transmission networks. Phylogenetic assessments may be used to enhance tracking of HIV-1 and other disease entities with high mutation rates, such as Ebola [13] . 
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